| Announce Date | 01/28/2026 |
| EPS Normalized Actual | $4.58 (Beat by $0.14) |
| EPS GAAP Actual | $4.58 (Beat by $0.14) |
| Revenue Actual | $14.999B |
| Revenue Surprise | Beat by $14999M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 15.16 | 13.74 | 14.84228 | 15.47841 | 4 |
| Nov 2028 | 16.16491 | 12.89 | 16.04078 | 16.28904 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 3.02 | 3.02 | 14.999B | -35.12% | 14999M |
| FQ3 2025 (Sep 2025) | 4.45 | 4.45 | 22.502B | 12.4% | 22502M |
| FQ2 2025 (Jun 2025) | 5.42 | 5.42 | 21.995B | 19.25% | 21995M |
| FQ1 2025 (Mar 2025) | 4.38 | 4.38 | 0B | -INF% | 0M |
| FQ4 2024 (Dec 2024) | 4.02 | 4.02 | 20.2672B | 20.68% | 20267.2M |
| FQ3 2024 (Sep 2024) | 3.98 | 3.98 | 19.7118B | 21.1% | 19711.8M |
| FQ2 2024 (Jun 2024) | 2.49 | 2.49 | 17.7609B | 13.59% | 17760.9M |
| FQ1 2024 (Mar 2024) | 3.94 | 3.94 | 17.2368B | 17.05% | 17236.8M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 3.4063 | -- | 3.33195 | 3.52019 | 6 |
| FQ3 2028 (Aug 2028) | 3.27818 | -- | 3.15181 | 3.4453 | 11 |
| FQ2 2028 (May 2028) | 3.61276 | -- | 3.47349 | 3.79694 | 10 |
| FQ1 2028 (Feb 2028) | 4.42785 | -- | 4.25716 | 4.65358 | 8 |
| FQ4 2027 (Dec 2027) | 4.3978 | -- | 4.07589 | 4.73475 | 5 |
| FQ3 2027 (Aug 2027) | 3.58039 | -- | 3.44237 | 3.76292 | 7 |
| FQ2 2027 (May 2027) | 3.78111 | -- | 3.63536 | 3.97387 | 6 |
| FQ1 2027 (Feb 2027) | 4.33493 | -- | 4.16783 | 4.55592 | 5 |
| FQ4 2026 (Dec 2026) | 3.61155 | 16.38 | 3.4034 | 3.79963 | 9 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 36.06B | -- | 35.45B | 36.98B | 2 |
| FQ3 2028 (Aug 2028) | 25.58B | -- | 24.82B | 26.58B | 2 |
| FQ2 2028 (May 2028) | 24.22B | -- | 23.5B | 25.17B | 3 |
| FQ1 2028 (Feb 2028) | 26.88B | -- | 26.09B | 27.94B | 3 |
| FQ4 2027 (Dec 2027) | 23.53B | -- | 22.21B | 24.92B | 3 |
| FQ3 2027 (Aug 2027) | 25.42B | -- | 24.67B | 26.42B | 6 |
| FQ2 2027 (May 2027) | 24.05B | -- | 23.33B | 24.99B | 3 |
| FQ1 2027 (Feb 2027) | 25.58B | -- | 24.82B | 26.58B | 6 |
| FQ4 2026 (Dec 2026) | 20.5B | 26.84 | 19.59B | 21.32B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 3.02 | 3.02 | 100% | |
| FQ3 2025 (Sep 2025) | 4.45 | 4.45 | 100% | |
| FQ2 2025 (Jun 2025) | 5.42 | 5.42 | 100% | |
| FQ1 2025 (Mar 2025) | 4.38 | 4.38 | 100% | |
| FQ4 2024 (Dec 2024) | 4.02 | 4.02 | 100% | |
| FQ3 2024 (Sep 2024) | 3.98 | 3.98 | 100% | |
| FQ2 2024 (Jun 2024) | 2.49 | 2.49 | 100% | |
| FQ1 2024 (Mar 2024) | 3.94 | 3.94 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $15B | $14999M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $22.5B | $22502M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $22B | $21995M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Dec 2024) | $0B | $20.27B | $20267.2M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $19.71B | $19711.8M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $17.76B | $17760.9M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $17.24B | $17236.8M | 100% |